Estimated prevalence in 2020 and 2030 under MPOWER policies with 100% price increase
| WHO region | Prevalence in 2010 | Estimated prevalence in 2020 with MPOWER package implemented in 2010 with 100% price increase | Estimated prevalence in 2030 with MPOWER package implemented in 2010 with 100% price increase | ||||
| Best case | Expected | Worst case | Best case | Expected | Worst case | ||
| AFRO | 15.8 | 11.6 | 12.1 | 12.4 | 10.6 | 11.3 | 11.9 |
| AMRO | 20.5 | 11.1 | 11.6 | 12.0 | 8.3 | 8.9 | 9.4 |
| EMRO | 22.4 | 13.9 | 15.1 | 16.3 | 11.3 | 13.0 | 14.6 |
| EURO | 31.2 | 17.1 | 18.2 | 19.2 | 13.7 | 15.1 | 16.4 |
| SEARO | 20.1 | 13.3 | 13.5 | 13.7 | 11.4 | 11.7 | 12.0 |
| WPRO | 28.5 | 19.2 | 19.4 | 19.6 | 16.7 | 17.0 | 17.4 |
| All regions | 23.7 | 15.0 | 15.4 | 15.8 | 12.5 | 13.2 | 13.7 |